SCHEMBL25227613

SCHEMBL25227613

COC(=O)c1cc(F)cc(-c2ccnc(OC)c2)c1Cl.O=C(O)c1cc(F)cc(-c2cc[nH]c(=O)c2)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 1/20 0.41
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ NR4A2 P43354 1/20 0.36
▸ DHODH Q02127 1/20 0.36
▸ POLQ O75417 1/20 0.35
▸ CNR1 P21554 1/20 0.35
▸ SCN8A Q9UQD0 4/20 0.35
▸ SCN10A Q9Y5Y9 4/20 0.35
▸ EGLN1 Q9GZT9 4/20 0.34
▸ PRKAG1 P54619 1/20 0.34
▸ PRKAA1 Q13131 1/20 0.34
▸ PRKAB1 Q9Y478 1/20 0.34
▸ CYP46A1 Q9Y6A2 1/20 0.34
▸ SORT1 Q99523 1/20 0.34
▸ LRRK2 Q5S007 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ ALDH2 P05091 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25281510 0.86 CNR1 (0.43) PDE3BPDE3ANR4A2DHODHCNR1
SCHEMBL31055668 0.81 MGLL (0.48) MGLLSCN8ASCN10ADYRK1AALDH2
SCHEMBL25232491 0.77 PRKAG1 (0.49) MGLLPDE3BPDE3APRKAG1PRKAA1
SCHEMBL25276173 0.77 PRKAG1 (0.49) MGLLPDE3BPDE3APRKAG1PRKAA1
SCHEMBL22866621 0.74 CYP46A1 (0.40) PDE3BPDE3ANR4A2DHODHCNR1
SCHEMBL31055692 0.72 PRKAG1 (0.46) PDE3BPDE3APOLQPRKAG1PRKAA1
SCHEMBL25276617 0.72 PRKAG1 (0.46) PDE3BPDE3APOLQPRKAG1PRKAA1
SCHEMBL19892431 0.72 MAPK14 (0.40) PDE3BPDE3ANR4A2DHODHPOLQ
SCHEMBL29628231 0.70 SLC6A3 (0.46) NR4A2POLQALDH2
SCHEMBL22867141 0.69 NLRP3 (0.41) PDE3BPDE3ANR4A2DHODHCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023110958-A1 BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-06-22 — — WO disclosed
Send feedback